Pricing Log in Create free account

BioNTech SE Sponsored ADR (BNTX) vs Insmed, Inc. (INSM)

BioNTech SE Sponsored ADR and Insmed, Inc. are both Biotechnology companies. Insmed, Inc. is the larger, with a market value of $23.9B against $21.6B — 1.1× the size. Insmed, Inc. grew revenue faster over the last twelve months: 240.0% against −22.7%. Insmed, Inc. has the higher net margin (−39.9% vs −63.8%) and the lower return on invested capital (−247.6% vs −34.3%). Across the 18 metrics below, BioNTech SE Sponsored ADR leads on 11 and Insmed, Inc. on 7.

Valuation

Metric BNTX INSM Biotechnology median
P/E n/m n/m 10.26
P/S 7.88 15.60 9.18
P/B 1.05 32.64 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 1.84 15.36 8.98
Earnings yield (7.93%) (2.60%) (34.89%)
Free cash flow yield (2.44%) (2.65%) (24.52%)

Profitability

Metric BNTX INSM Biotechnology median
Gross margin 74.59% 84.40% 65.16%
Operating margin (78.99%) (37.11%) 0.00%
Net margin (63.77%) (39.85%) 0.00%
Free cash flow margin (19.21%) (41.30%) 0.00%
Return on equity (8.29%) (72.45%) (50.12%)
Return on assets (7.22%) (26.41%) (45.60%)
Return on invested capital (34.28%) (247.55%) 0.00%

Growth

Metric BNTX INSM Biotechnology median
Revenue growth (TTM) (22.73%) 239.97% 6.26%
EPS growth (last fiscal year) (77.33%) (15.26%) 29.88%
Revenue growth, 5-year CAGR 42.58% 29.83% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTX INSM Biotechnology median
Debt to equity 0.02 0.78 0.00
Current ratio 8.55 2.86 4.89
Net debt to EBITDA 14.29 0.71 1.01

Dividend

Metric BNTX INSM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BNTX INSM Biotechnology median
Market cap 21.57b 23.86b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack